Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
Timing is everything: Novel Combinatorial Approaches to Overcome the Immunosuppression in Prostate Cancer
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK Cells
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Cognitive Decline and Alzheimer’s Linked to Low Systemic REST Levels and Deficient Stress Protection of the Aging Brain
Norepinephrine through β2-adrenoceptor activation down-regulates pro-inflammatory pathogenic Th17 cells in a rodent model of rheumatoid arthritisMarch 20, 2018
Inhibitors of RORγt: Targeting Th17 Cells and Therapeutic Potential in Inflammation & AutoimmunityJanuary 26, 2016
New Evidence that Peripheral Nerves Sense Infection and Drive IL-23 Production by Skin Dendritic CellsOctober 22, 2015
Pro-Inflammatory Th17 Cells and Glucocorticoid Resistance: Implications for Chronic Inflammatory Diseases and Their TreatmentMay 16, 2017
Th17 Cells and Lymphotoxin: Conductors for the Tertiary Lymphoid Tissues and Inflammation OrchestraJuly 1, 2016
Autism-Like Symptoms in Mice: the link to the Th17–IL-17–IL-17R System and an Altered Brain DevelopmentMarch 3, 2016
Vasoactive Intestinal Peptide Inhibits Pathogenic Th17 Cells from Rheumatoid Arthritis PatientsMay 27, 2015
